[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "alpha1-proteinase inhibitor;Antiviral Agents", "treatment_type": "Drug;Drug", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Antiviral Agents", "treatment_type": "Drug", "pharmacological_treatment": "Pharmacological treatment"}]

[{"arm_notes": "a single loading dose of Remdesivir 200 mg on Day 1 followed by once-daily maintenance doses of Remdesivir 100 mg from Day 2 infused over 30 to 120 minutes", "treatment_id": 1099, "treatment_name": "Remdesivir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "alpha1-proteinase inhibitor, administered as a loading dose of 120mg/kg/body weight intravenous infusion on the first day, and then 60mg/kg/BW intravenous infusion on Days 3, 5, 7 and 9. Booster infusion of 120 mg/kg/BWon Day 17.\n\nThe Antiviral treatment is Remdesivir. For patients not requiring invasive mechanical ventilation and/or ECMO, the recommended total treatment duration is 5 days. If a patient does not demonstrate clinical improvement, treatment may be extended for up to 5 additional days for a total treatment duration of up to 10 days. Recommended dosage in adults and pediatric patients 12 years of age and older and weighing at least 40 kg: a single loading dose of Remdesivir 200 mg on Day 1 followed by once-daily maintenance doses of Remdesivir 100 mg from Day 2 infused over 30 to 120 minutes", "treatment_id": 2273, "treatment_name": "Human alpha-1-proteinase inhibitor+remdesivir", "treatment_type": "Advanced therapy medicinal products (atmp)+antivirals", "pharmacological_treatment": "Biological treatment+pharmacological treatment"}]